MYM. MYM Nutraceuticals Inc

MYM Nutraceuticals, New Manufacturing Facility for Cannabis Consumables, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - November 2, 2018) - Rob Gietl, CEO of MYM Nutraceuticals explains how their cannabis company aims to focus on the medical industry.



If you cannot view the video above, please visit:

MYM Nutraceuticals is being featured on BNN Bloomberg on Nov. 3 - Nov. 4, 2018 Monday through Friday, throughout the day and evenings.

MYM Nutraceuticals (CSE: MYM)

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in Canada and the US. These 90 second video profiles broadcast on national TV and online via 15 top financial sites including: Thomson Reuters, Bloomberg, Yahoo! Finance and Stockhouse.com.

BTV - Business Television/CEO Clips Contact: Trina Schlingmann (604) 664-7401 x 5

EN
02/11/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MYM Nutraceuticals Inc

 PRESS RELEASE

MYM Obtains Final Order for Arrangement with IM Cannabis Corp.

MYM Obtains Final Order for Arrangement with IM Cannabis Corp. VANCOUVER, British Columbia, July 08, 2021 (GLOBE NEWSWIRE) -- MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”), is pleased to announce that it has been granted the final court order from the Supreme Court of British Columbia approving the plan of arrangement (the “Arrangement”) with IM Cannabis Corp. (“IMC”), pursuant to which, among other things, IMC, through its wholly-owned subsidiary Trichome Financial Corp., will acquire all of the issued and outstanding common shares of MYM (the “MYM Shares”) ...

 PRESS RELEASE

MYM Shareholders Approve Plan of Arrangement with IM Cannabis

MYM Shareholders Approve Plan of Arrangement with IM Cannabis VANCOUVER, British Columbia, July 05, 2021 (GLOBE NEWSWIRE) -- MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”), is pleased to announce that, at its special meeting (the “MYM Meeting”) of shareholders of MYM (“MYM Shareholders”), MYM Shareholders approved the plan of arrangement (the “Arrangement”) with IM Cannabis Corp. (“IMC”) originally announced April 1, 2021, pursuant to which, among other things, IMC will acquire all of the issued and outstanding common shares of MYM (“MYM Shares”) for considera...

 PRESS RELEASE

MYM’s Acquisition by IMCC Receives Positive Recommendations from leadi...

MYM’s Acquisition by IMCC Receives Positive Recommendations from leading Independent Proxy Advisory Firms Glass Lewis and Institutional Shareholder Services recommend that MYM shareholders vote FOR Transaction with IMCC Over 90% of committed and tallied common shares are being voted in favour of the Transaction VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) -- MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”) is pleased to announce that both Glass, Lewis & Co. (“Glass Lewis”) and Institutional Shareholder Services Inc. (“ISS”), the two leading inde...

 PRESS RELEASE

MYM Provides Timeline for Special Meeting of Shareholders and Announce...

Vancouver, British Columbia--(Newsfile Corp. - May 25, 2021) -  MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") published a notice of meeting and record date for the upcoming special meeting of shareholders of MYM (the "Meeting") disclosing that the record date will be May 31, 2021 and the Meeting will be on July 5, 2021. At the Meeting, shareholders will be asked to consider and vote on a special resolution approving, among other things, the arrangement agreement entered into on March 31, 2021 between MYM, IM Cannabis Corp., and Trichome Financial Corp. (the "Arrang...

 PRESS RELEASE

MYM Releases Q3 2021 Financial Results

Vancouver, British Columbia--(Newsfile Corp. - April 30, 2021) - MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") today announced its financial results for the three-month period ending February 28, 2021 ("Q3 2021"). The Company's Financial Statements and Management Discussion & Analysis ("MD&A") are available on . Key Highlights for Q3 2021Gross revenue of $4.4 million, an increase of 8% from the prior quarterPositive EBITDA of $212,628Expanded distribution to three new markets: Yukon, Nunavut, and OntarioSubsequent to Q3 2021, announced a definitive agreement to m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch